Grace Capital

13F Filings History

Latest 13F report
Q4 2021 - Feb 2, 2022
Value $
$163M
Signature - Title
Sami Nasir - Research Analyst
Location
Quincy, MA
Summary
This page shows a list of all the recent 13F filings made by Grace Capital. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Grace Capital reported 144 stock holdings with total value $163M as of Q4 2021. Top holdings included AAPL, MDB, RLAY, TPL, and SPY.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2021 144 $163M +$11.6M -$12.4M -$825K AAPL, MDB, RLAY, TPL, SPY 13F-HR 2/2/2022, 12:24 PM
Q3 2021 162 $153M +$22.3M -$5.72M +$16.6M AAPL, MDB, RLAY, TPL, SPY 13F-HR 11/8/2021, 04:36 PM
Q2 2021 158 $146M +$8.85M -$27.1M -$18.2M RLAY, AAPL, TPL, AMZN, BBIO 13F-HR 8/11/2021, 03:17 PM
Q1 2021 208 $155M +$11.5M -$16.9M -$5.39M TPL, RLAY, AAPL, GBT, BBIO 13F-HR 5/6/2021, 12:22 PM
Q4 2020 255 $153M +$26.6M -$15.2M +$11.4M AAPL, RLAY, GBT, BBIO, AMZN 13F-HR 2/10/2021, 11:58 AM
Q3 2020 239 $127M +$23.6M -$16.5M +$7.13M RLAY, GBT, AAPL, SAFT, AMZN 13F-HR 11/12/2020, 04:16 PM
Q2 2020 215 $111M +$13.7M -$24.6M -$10.9M GBT, SAFT, AMZN, SPY, BBIO 13F-HR 8/13/2020, 09:59 AM
Q1 2020 181 $102M +$19.2M -$11.3M +$7.87M GBT, SAFT, SPY, AMZN, MYOK 13F-HR 5/12/2020, 12:27 PM
Q4 2019 193 $121M +$26.2M -$19.4M +$6.79M GBT, SAFT, PTLA, MYOK, TPL 13F-HR 2/13/2020, 01:34 PM
Q3 2019 137 $98M +$8.45M -$119M -$110M GBT, PTLA, MYOK, IVV, TPL 13F-HR 11/15/2019, 03:47 PM
Q2 2019 180 $209M +$14.9M -$65.4M -$50.6M GBT, PTLA, AAPL, MSFT, MYOK 13F-HR 8/14/2019, 04:07 PM
Q1 2019 201 $255M +$58.5M -$44.1M +$14.4M GBT, PTLA, AAPL, MSFT, JPM 13F-HR 5/15/2019, 04:18 PM
Q4 2018 212 $215M +$54.3M -$54.9M -$590K MSFT, PFE, MYOK, PTLA, AAPL 13F-HR 2/15/2019, 12:06 PM
Q3 2018 208 $250M +$17.5M -$42.7M -$25.3M GBT, AAPL, MSFT, MYOK, IWM Restatement 11/14/2018, 03:05 PM
Q2 2018 220 $246M +$127M -$69.1M +$58M MYOK, AAPL, MSFT, IWM, JPM 13F-HR 8/14/2018, 07:44 PM
Q1 2018 88 $188M +$26.6M -$111M -$84.4M BAC, JPM, MSFT, AAPL, STI Restatement 9/5/2018, 04:39 PM
Q4 2017 80 $284M +$51.5M -$53.8M -$2.33M MSFT, AAPL, JPM, BAC, C 13F-HR 2/12/2018, 04:37 PM
Q3 2017 87 $275M +$57.7M -$38.1M +$19.6M AAPL, MSFT, JPM, CHKP, META 13F-HR 11/13/2017, 11:26 AM
Q2 2017 94 $250M +$20.2M -$15.1M +$5.1M AAPL, MSFT, EPD, JPM, TCP 13F-HR 8/11/2017, 09:48 AM
Q1 2017 89 $243M +$45.1M -$30.3M +$14.8M AAPL, MSFT, TCP, EPD, JPM 13F-HR 5/2/2017, 04:36 PM
Q4 2016 78 $220M +$33.9M -$36.9M -$2.95M MSFT, EPD, TCP, JPM, AAPL 13F-HR 1/17/2017, 02:18 PM
Q3 2016 77 $229M +$28.5M -$34M -$5.56M EPD, BGS, MSFT, HP, TCP 13F-HR 10/4/2016, 11:39 AM
Q2 2016 75 $238M +$22.4M -$19.5M +$2.91M EPD, SPH, APU, HP, BGS 13F-HR 7/8/2016, 09:54 AM
Q1 2016 83 $223M +$20M -$15.9M +$4.14M OMC, APU, FI, MCHP, AAPL 13F-HR 4/7/2016, 10:51 AM
Q4 2015 89 $210M +$46.5M -$55.3M -$8.82M OMC, MCHP, FI, AAPL, MSFT 13F-HR 2/11/2016, 04:09 PM
Q3 2015 107 $212M $0 $0 OMC, GSK, AAPL, AVY, MOH 13F-HR 11/10/2015, 01:55 PM
Q2 2015 107 $243M +$19.9M -$207M -$187M OMC, GSK, AAPL, AVY, MOH 13F-HR 8/10/2015, 04:33 PM
Q1 2015 98 $445M +$102M -$77.1M +$24.9M AAPL, MCHP, OMC, GSK, MOH 13F-HR 5/11/2015, 01:51 PM
Q4 2014 97 $416M +$80.8M -$19.2M +$61.6M KMI, TCP, NVS, FI, PH Restatement 2/18/2015, 11:11 AM
Q3 2014 94 $352M +$24.6M -$26.3M -$1.66M TCP, EPD, NVS, BPL, FI 13F-HR 10/15/2014, 09:08 AM
Q2 2014 98 $364M +$264M -$97.2K +$264M EPD, BPL, GIS, OKS, NVS 13F-HR 7/30/2014, 01:02 PM
Q1 2014 81 $95.3M +$9.88M -$775K +$9.11M ADP, FI, BCR, PB, HRL 13F-HR 4/29/2014, 09:37 AM
Q4 2013 80 $86.5M $0 $0 ADP, FI, PH, PB, BCR 13F-HR 1/21/2014, 03:33 PM